Adopt the Ensuring Transparency in Prior Authorization Act and provide for insurance and medicaid coverage of biomarker testing

Bill was renumbered from an amendment document to a full legislative bill for the 2025 session, with updated introduction and committee information.

Added comprehensive definitions section (Sec. 2) establishing terms like 'adverse determination,' 'clinical peer,' 'emergency health care services,' 'urgent health care service,' and 'utilization review agent' with references to existing statutes.

Added requirements for utilization review agents to make prior authorization requirements and clinical review criteria accessible on their websites, with searchable format required by July 1, 2027.

Added notice requirements mandating that utilization review agents provide contracted health care providers with at least 60 days notice before implementing new or amended prior authorization requirements.

Added requirement that adverse determinations for prior authorization be made by a physician or clinical peer with appropriate training and expertise.